Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Parveen Bahel"'
Autor:
Alexander B. Pine, Matthew L. Meizlish, George Goshua, C-Hong Chang, Hanming Zhang, Jason Bishai, Parveen Bahel, Amisha Patel, Rana Gbyli, Jennifer M. Kwan, Christine H. Won, Christina Price, Charles S. Dela Cruz, Stephanie Halene, David van Dijk, John Hwa, Alfred I. Lee, Hyung J. Chun
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
Increase in thrombotic and microvascular complications is emerging to be a key feature of patients with critical illness associated with COVID-19 infection. While endotheliopathy is thought to be a key factor of COVID-19-associated coagulopathy, mark
Externí odkaz:
https://doaj.org/article/b63ebb34edc7417bac3ae646450b6612
Autor:
Cecily Allen, Ayesha Butt, Xiwen Zhao, Fangyong Li, Parveen Bahel, C-Hong Chang, Hyung Chun, Sean Gu, John Hwa, Sofia Jakab, Bonnie Chen, Guadalupe Garcia-Tsao, Henry Rinder, Uyen To, Matthew McConnell, Alfred I Lee, Alexander Pine
Publikováno v:
Blood. 140:8382-8383
Autor:
Parveen Bahel, Alexa J. Siddon, Gaurav K. Gupta, Jeanne E. Hendrickson, Christopher A. Tormey, Henry M. Rinder
Publikováno v:
Transfusion. 61:405-409
BACKGROUND Allogeneic platelet (PLT) infusion is a strategy to raise Factor V (FV) levels in patients with congenital FV deficiency. However, since FV is labile in vitro, we hypothesized that FV activity could be low in PLT units. STUDY DESIGN AND ME
Autor:
Jane A. O’Halloran, C-Hong Chang, Rachel M. Presti, Xiaobo Wu, Rebecca E Schriefer, Alfred H.J. Kim, Vasanthan Kuppuswamy, Hanming Zhang, Parveen Bahel, Henry M. Rinder, John P. Atkinson, George Goshua, Andrew E. Gelman, Sanjaya Kumar Sahu, Hyung J. Chun, Phillip Mudd, Tingting Lei, Lina Ma, Aaron Day, Christina Price, Hrishikesh S. Kulkarni, Alexander B Pine, Charles S. Dela Cruz, Daniel Reynolds, Charles W. Goss, Adriana M Rauseo, Matthew L Meizlish, Ja’Nia McPhatter, Jamal Bajwa, Marlene Cano, Alfred Ian Lee
Publikováno v:
bioRxiv
Science Immunology
Science Immunology
Complement activation has been implicated in the pathogenesis of severe SARS-CoV-2 infection. However, it remains to be determined whether increased complement activation is a broad indicator of critical illness (and thus, no different in COVID-19).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::024a48a1a95ceab7866d42575218fed0
https://europepmc.org/articles/PMC7924264/
https://europepmc.org/articles/PMC7924264/
Autor:
Hyung J. Chun, Matthew L Meizlish, C-Hong Chang, Henry M. Rinder, Stephen Y Wang, Alfred Ian Lee, Parveen Bahel
Publikováno v:
medRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
As the global community strives to discover effective therapies for COVID-19, immunomodulatory strategies have emerged as a leading contender to combat the cytokine storm and improve clinical outcomes in patients with severe disease. Systemic cortico
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbb5e977b8124a91da359ad3faa66139
https://doi.org/10.1101/2020.12.23.20248547
https://doi.org/10.1101/2020.12.23.20248547
Autor:
Parveen Bahel, Christine Won, Matthew L Meizlish, David van Dijk, Hyung J. Chun, Jennifer M. Kwan, Alexander B Pine, Stephanie Halene, Christina Price, C-Hong Chang, Charles S. Dela Cruz, Alfred Ian Lee, Hanming Zhang, Jason Bishai, Rana Gbyli, Amisha Patel, John Hwa, George Goshua
Publikováno v:
Pulmonary Circulation
medRxiv
Pulmonary Circulation, Vol 10 (2020)
medRxiv
Pulmonary Circulation, Vol 10 (2020)
Increase in thrombotic and microvascular complications is emerging to be a key feature of patients with critical illness associated with COVID-19 infection. While endotheliopathy is thought to be a key factor of COVID-19-associated coagulopathy, mark
Autor:
Christine Won, John Hwa, Emily R. Nadelmann, Deepak Atri, Michael Simonov, Jennifer M. Kwan, Hyung J. Chun, Yu Yamamoto, David van Dijk, Brett King, Stephanie Halene, Alfred Ian Lee, Parveen Bahel, Henry M. Rinder, Charles S. Dela Cruz, Christina Price, F. Perry Wilson, Jason Bishai, Rana Gbyli, C-Hong Chang, George Goshua, Jonathan L. Koff, Marcus Shallow, Kent A. Owusu, Alexander B Pine, Tanima Arora, Amisha Patel, Hanming Zhang, William Damsky, Matthew L Meizlish
Publikováno v:
Blood Advances
medRxiv
medRxiv
Pathologic immune hyperactivation is emerging as a key feature of critical illness in COVID-19, but the mechanisms involved remain poorly understood. We carried out proteomic profiling of plasma from cross-sectional and longitudinal cohorts of hospit
Autor:
George Goshua, Alexander B Pine, Alfred Ian Lee, Jonathan L. Koff, Christopher A. Tormey, Hanming Zhang, Jonathan M. Siner, Parveen Bahel, Hope Menninger, Hyung J. Chun, Robert D Bona, Henry M. Rinder, Christina Price, Audrey Baluha, Adrienne J Burns, Natalia Neparidze, Matthew L Meizlish, John Hwa, Stephanie Halene, C-Hong Chang, Noffar Bar, Anne Dumont, Charles S. Dela Cruz
Publikováno v:
The Lancet. Haematology
The Lancet Haematology
The Lancet Haematology
Summary Background An important feature of severe acute respiratory syndrome coronavirus 2 pathogenesis is COVID-19-associated coagulopathy, characterised by increased thrombotic and microvascular complications. Previous studies have suggested a role
Autor:
Parveen Bahel, Richard Torres, Henry M. Rinder, Jocelyn B. Chandler, Alexa J. Siddon, Christopher A. Tormey
Publikováno v:
Journal of Clinical Pathology. 72:177-180
Most fibrinogen replacement strategies focus on quantitative deficiencies. A thrombin time (TT) mixing study helped to assess qualitative defects caused by dysfibrinogens. Plasma samples were collected from non-anticoagulated subjects (n=6) meeting l
Autor:
Gaurav K. Gupta, Parveen Bahel, Jeanne E. Hendrickson, Alexa J. Siddon, Henry M. Rinder, Christopher A. Tormey
Publikováno v:
American Journal of Clinical Pathology. 154:S6-S7
Introduction Factor V (FV) deficiency is a rare but significant disorder associated with potentially life-threatening bleeding. Management may involve plasma infusion to increase FV activity. Although the majority (~80%) of FV is present in the plasm